NCT06010368View on ClinicalTrials.gov

Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

January 1, 2026

Conditions

Cesarean Section ComplicationsTranexamic AcidOxytocinPost Partum Hemorrhage

Interventions

DRUG

Tranexamic acid injection

In TXA group (n=75): 1 g from tranexamic acid (kapron®, Amoun, Egypt) shall also be watered down in 10 cc of Saline, and 5 cc shall be injected in each uterine corn before the placenta is separated.

DRUG

Oxytocin

the oxytocin group (n = 75): 5 I.U of oxytocin (syntocinone 5 I.U/1ML NONARTIS-EGYPT) shall be watered down in 10 cc of saline, and 5 cc shall be injected into each uterine corn before the placental separation

Trial Locations (1)

8366004

Suez Canal University, Ismailia

All Listed Sponsors

lead

Cairo University

OTHER

NCT06010368 - Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section | Biotech Hunter | Biotech Hunter